Baxter voluntarily recalls one lot of anticoagulant sodium citrate solution over possible fiberglass particles
Baxter International announced a voluntary recall of a single lot of its Anticoagulant Sodium Citrate Solution, USP, 250 mL, packaged in a VIAFLEX plastic container.
The recall was triggered after testing identified potential fiberglass particulate matter in the solution. The particles could cause vein irritation, inflammatory or hypersensitivity reactions, and, without inline filtration, could lead to systemic embolization.
The product is used with automated apheresis devices and is not intended for direct intravenous infusion. Baxter reported no adverse events linked to the issue as of the announcement date, August 25 2026.
This writeup was produced by pharmadog from original reporting by fda medwatch.
Original headline: “Baxter Issues Voluntary Nationwide Recall for One Lot of Anticoagulant Sodium Citrate Solution Due to Potential Presence of Particulate Matter”
read at fda medwatch ↗
comments(0)
5-min edit window · permanent after that